Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Odds Ratio
Hazard Ratio
Testing a Claim about Population Proportion
Receiver Operating Characteristic Plot
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 3, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Etsuji Suzuki1, David Evans, Basile Chaix
1Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan, etsuji-s@cc.okayama-u.ac.jp European Centre for Observational Research and Data Sciences, Bristol-Myers Squibb, Rueil-Malmaison, France, Université Pierre et Marie Curie-Paris6, UMR-S 707, Paris, France Université Pierre et Marie Curie-Paris6, Inserm, U707, Paris, France UMR-S 707, Paris, France Departments of Epidemiology and Biostatistics, Harvard School of Public Health, Boston, MA.
No abstract available in PubMed .